Latest News
|
22 May 2013
1 Likes 
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Accuracy of Blood Glucose Meters Draws FDA Scrutiny (KHN) (Medical Daily) Law Firm: FDA's
Read More...
Latest News
|
21 May 2013
0 Likes
The US Food and Drug Administration (FDA) has announced its third meeting on patient-focused drug development, this time focusing on the views of patients with lung cancer and seeking to identify
Read More...
Latest News
|
21 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Merck Insomnia Drug Suvorexant Safer at Lower Dose, FDA Staff Says (Bloomberg) (Reuters)
Read More...
Latest News
|
20 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US NYTimes Reports Chinese Hackers Going After, Among Other Things, Clinical Trials Results
Read More...
Latest News
|
17 May 2013
0 Likes
Hello and welcome to a new edition of Five in Focus, our Friday recap of the five most important, interesting, riveting or ground-breaking stories of the week.FDA's Big Week for Device Guidance and
Read More...
Latest News
|
17 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Is the Hatch-Waxman Act Flawed and Should the Supreme Court Fix It? (Becker's Hospital
Read More...
Latest News
|
16 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: Special Edition Dirty Medicine: The Epic Story of Criminal Fraud at Ranbaxy (Fortune)
Read More...
Latest News
|
15 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Fraud Cases' Impact on Ranbaxy May Climb as High as $1 Billion (India Times) Confusion
Read More...
Latest News
|
14 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US US Government Files Morning-After Pill Appeal (AP) (WSJ) (CBS) (The Hill) (SCOTUS Blog)
Read More...
Regulatory Update
|
13 May 2013
0 Likes
The Committee on Social Security and Family of Brazil’s House of Representatives held a hearing on 9 May 2013 on the scope of regulatory authority of Brazil’s National Health Surveillance Agency
Read More...